Newsroom
For media inquiries, please contact 340B Health Senior Vice President of Communications Jon Tilton at jon.tilton@340bhealth.org or 202-536-2285.
-
340B HEALTH BOARD ELECTS TWO NEW MEMBERS
-
How drugmaker restrictions on 340B discounts affect hospital pharmacies: 5 systems weigh in
-
STATEMENT ON FEDERAL 340B ENFORCEMENT ACTIONS AGAINST BOEHRINGER INGELHEIM
-
SIX DRUG COMPANIES REFERRED FOR PENALTIES FOR CONTINUED VIOLATIONS OF FEDERAL LAW ON 340B PRICING
-
DIABETES DRUGS HEAVILY IMPACTED BY DRUGMAKERS’ 340B POLICIES
-
STATEMENT ON MERCK CUTTING OFF 340B DISCOUNTS THROUGH COMMUNITY-BASED PHARMACIES
-
STATEMENT ON HOUSE LANGUAGE IN SUPPORT OF ENDING DRUG COMPANY ATTACKS ON 340B
-
STATEMENT ON PROPOSED MEDICARE PAYMENT CUTS TO 340B HOSPITALS IN 2022
-
STATEMENT ON THE BIPARTISAN PROTECT 340B ACT TO STOP DISCRIMINATORY ACTIONS BY PBMS AND INSURERS
-
340B HEALTH CALLS ON BOEHRINGER INGELHEIM TO WITHDRAW THREAT TO DENY DRUG DISCOUNTS TO SAFETY-NET HOSPITALS
-
STATEMENT ON U.S. SUPREME COURT ORDER IN 340B MEDICARE CUTS LAWSUIT
-
STATEMENT ON WITHDRAWAL OF HHS ADVISORY OPINION ON 340B COMMUNITY PHARMACIES